top of page

New Exploratory Alzheimer's Drug ANAVEX 2-73: Assessment of Safety and Cognitive Performance

  • Writer: ANAVEX® Life Sciences Corp.
    ANAVEX® Life Sciences Corp.
  • Nov 27, 2015
  • 1 min read

International Conference on Clinical Trials for Alzheimer’s Disease (CTAD) 2015, Barcelona, Spain

Steve Macfarlane, Paul Maruff, Marco Cecchi, Dennis Moore, Tasos Zografidis, Christopher Missling


 
 
bottom of page